GHRS · GH Research PLC · Metrics
Market Cap
$1.64B
Shares
68.64M
Volume · Oct 5
206.96K
Avg daily vol (3M)
287.15K
GHRS metrics
51 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$22.17
Market cap
$1.64B
Price action
20 metricsPrice change (1W)
-3.8%
Price change (30D)
-17.5%
Price change (3M)
-15.1%
Price change (6M)
+57.4%
Price change (YTD)
+80.6%
Price change (1Y)
+72.0%
Trailing year
Price change (5Y)
+6.4%
52-week high
$30.64
52-week low
$12.49
Change from 52-week high
-25.1%
Change from 52-week low
+83.7%
Annualized volatility
71.9%
Annualized volatility (3M)
47.1%
Beta
1.5
RSI (14D)
31.0
Price vs SMA 50
-17.3%
Price vs SMA 200
+9.4%
Avg volume (3M)
288,404
Relative volume
0.8
Average dollar volume
$8.00M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
68.64M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
5.9
reciprocal yield 17.1%
FCF yield
-2.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-2.9%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$60.72M
Net income (TTM)
−$48.26M
Trailing 12 months
Diluted EPS (TTM)
$-0.79
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+19.2%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-17.3%
Return on assets
-16.7%
Debt / equity
—
Current ratio
34.1
EBITDA (TTM)
—
Free cash flow (TTM)
−$43.67M
Quick ratio
34.1
Interest coverage
-131.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$246.25M
Total assets
$288.23M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$43.55M
Capital expenditures (TTM)
$121,000
R&D (TTM)
$38.77M
SG&A (TTM)
—
Stock compensation (TTM)
$8.50M
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
64
13F filer change QoQ
+9
Institutional ownership
75.1%
Short interest
3 metricsShort interest
3.9%
Latest settlement · 14.3 days to cover
Days to cover
14.3d
Short-squeeze score
54 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—